M E Bigal

Summary

Publications

  1. ncbi request reprint Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study
    M E Bigal
    Departmet of Neurology, Albert Einstein School of Medicine, Bronx, NY, USA
    Braz J Med Biol Res 35:1139-45. 2002
  2. ncbi request reprint Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study
    M E Bigal
    Department of Neurology, Sao Paulo University, School of Medicine at Ribeirao Preto, 3900, 14049 900 Ribeirao Preto, SP, Brazil
    Cephalalgia 22:345-53. 2002
  3. ncbi request reprint Hemicrania continua: a report of ten new cases
    Marcelo E Bigal
    International Headache Society Fellow, The New England Center for Headache, New York, NY, USA
    Arq Neuropsiquiatr 60:695-8. 2002
  4. ncbi request reprint Chronic migraine is an earlier stage of transformed migraine in adults
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 65:1556-61. 2005
  5. ncbi request reprint Migraine in adolescents: association with socioeconomic status and family history
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 69:16-25. 2007
  6. ncbi request reprint Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study
    A M Rapoport
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Neurology 69:821-6. 2007
  7. ncbi request reprint Classification of primary headaches
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461 1926, USA
    Neurology 63:427-35. 2004
  8. ncbi request reprint Prevalence and impact of migraine and probable migraine in a health plan
    N V Patel
    AdvancePCS, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 63:1432-8. 2004
  9. ncbi request reprint Field testing alternative criteria for chronic migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:477-82. 2006
  10. ncbi request reprint Headache prevention outcome and body mass index
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:445-50. 2006

Collaborators

Detail Information

Publications85

  1. ncbi request reprint Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study
    M E Bigal
    Departmet of Neurology, Albert Einstein School of Medicine, Bronx, NY, USA
    Braz J Med Biol Res 35:1139-45. 2002
    ..6%) for the dipyrone group. Intravenous dipyrone is an effective drug for the relief of pain in tension-type headache and its use is justified in the emergency room setting...
  2. ncbi request reprint Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study
    M E Bigal
    Department of Neurology, Sao Paulo University, School of Medicine at Ribeirao Preto, 3900, 14049 900 Ribeirao Preto, SP, Brazil
    Cephalalgia 22:345-53. 2002
    ..Our data support the idea that magnesium sulphate can be used for the treatment of all symptoms in migraine with aura, or as an adjuvant therapy for associated symptoms in patients with migraine without aura...
  3. ncbi request reprint Hemicrania continua: a report of ten new cases
    Marcelo E Bigal
    International Headache Society Fellow, The New England Center for Headache, New York, NY, USA
    Arq Neuropsiquiatr 60:695-8. 2002
    ..Although the cardinal features of HC - continuous, unilateral, indomethacin responsive, remain strongly reliable, a refinement on the clinical characterization is needful and desired...
  4. ncbi request reprint Chronic migraine is an earlier stage of transformed migraine in adults
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 65:1556-61. 2005
    ..They are often classified as transformed migraine (TM), a disorder not addressed in the International Headache Society classification...
  5. ncbi request reprint Migraine in adolescents: association with socioeconomic status and family history
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 69:16-25. 2007
    ..The influence of socioeconomic status on the prevalence of migraine is unknown in adolescents. Accordingly, we investigated the prevalence of migraine in a large sample of adolescents by sociodemographic features...
  6. ncbi request reprint Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study
    A M Rapoport
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Neurology 69:821-6. 2007
    ..To evaluate the efficacy and tolerability of zolmitriptan 5 mg and 10 mg nasal spray (ZNS) vs placebo in the acute treatment of cluster headache. Design/..
  7. ncbi request reprint Classification of primary headaches
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461 1926, USA
    Neurology 63:427-35. 2004
    ..They conclude by presenting an approach to headache diagnosis based upon these criteria...
  8. ncbi request reprint Prevalence and impact of migraine and probable migraine in a health plan
    N V Patel
    AdvancePCS, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 63:1432-8. 2004
    ..A large number of headache sufferers with features of migraine fail to meet criteria for strict migraine (SM; migraine with or without aura) but do meet criteria for probable migraine (PM)...
  9. ncbi request reprint Field testing alternative criteria for chronic migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:477-82. 2006
    ..Consistently, criteria for CM and CM+ should be revised to require at least 8 days of migraine or probable migraine per month, in individuals with 15 or more days of headache per month...
  10. ncbi request reprint Headache prevention outcome and body mass index
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:445-50. 2006
    ..Contrary to what we hypothesized, obesity at baseline does not seem to be related to follow-up refractoriness to preventive treatment...
  11. ncbi request reprint Etiology and distribution of headaches in two Brazilian primary care units
    M E Bigal
    Department of Neurology, , , , SP, Brazil
    Headache 40:241-7. 2000
    ....
  12. ncbi request reprint Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 65:S50-8. 2005
    ..We consider clinical trials strategies designed to address the more complex clinical and policy requirements for meeting the needs of those with migraine...
  13. ncbi request reprint Migraine days decline with duration of illness in adolescents with transformed migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA
    Cephalalgia 25:482-7. 2005
    ..These findings suggest that early in the process of transformation, migraine is more frequent, and that as CDH evolves, fewer typical attacks of IHS migraine occur...
  14. ncbi request reprint The family impact of migraine: population-based studies in the USA and UK
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Cephalalgia 23:429-40. 2003
    ..02), with their level or responsibilities and duties (P = 0.02), and with their ability to perform (P = 0.001). Results from this study show that the impact of migraine extends to household partners and other family members...
  15. doi request reprint New daily persistent headache in the paediatric population
    E Kung
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 29:17-22. 2009
    ..On most days, they had migraine-associated symptoms (one of nausea, photophobia or phonophobia)). NDPH is common in children and adolescents with CDH. Most subjects do not overuse medication. Migraine features are common...
  16. ncbi request reprint Primary chronic daily headache and its subtypes in adolescents and adults
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Neurology 63:843-7. 2004
    ..To determine the relative frequency of chronic daily headache (CDH) subtypes in adolescents and to compare the distribution of CDH subtypes in adolescents and adults of various ages...
  17. ncbi request reprint Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache--a placebo-controlled study
    M E Bigal
    Department of Neurology, , , Av. Bandeirantes 3900, , SP, Brazil
    Cephalalgia 21:90-5. 2001
    ..Side-effects were mild and with small incidence. Metamizol is an effective, safe and low price drug. It may be regarded as a good alternative drug for the treatment of common acute primary headaches...
  18. ncbi request reprint The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Cephalalgia 27:230-4. 2007
    ..In the population where use of specific acute migraine medications is less common, the agreement between ICHD-2R CM and TM may be less robust...
  19. ncbi request reprint Epilepsy and migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Epilepsy Behav 4:S13-24. 2003
    ..We summarize the epidemiologic evidence that migraine and epilepsy are associated and discuss specific interrelationships between migraine and epilepsy...
  20. ncbi request reprint MMPI personality profiles in patients with primary chronic daily headache: a case-control study
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Rousso Building, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Neurol Sci 24:103-10. 2003
    ....
  21. ncbi request reprint Migraine prevalence, disease burden, and the need for preventive therapy
    R B Lipton
    Department of Neurology, The Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Neurology 68:343-9. 2007
    ....
  22. ncbi request reprint Persistent idiopathic facial pain responsive to topiramate
    M Volcy
    The New England Center for Headache, Stamford, CT 06902, USA
    Cephalalgia 26:489-91. 2006
  23. ncbi request reprint Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, NY, USA
    Cephalalgia 26:43-9. 2006
    ..Educational strategies should focus on physician education addressing diagnosing the full spectrum of migraine and physician management of migraine with specific migraine therapy in appropriate patients...
  24. ncbi request reprint Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Cephalalgia 24:483-90. 2004
    ..001). More rigorous prescribing guidelines for patients with frequent headaches are urgently needed. Successful detoxification is necessary to ensure improvement in the headache status when treating patients who overuse acute medications...
  25. pmc Prevalence and characteristics of allodynia in headache sufferers: a population study
    M E Bigal
    Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 70:1525-33. 2008
    ..The authors estimated the prevalence and severity of cutaneous allodynia (CA) in individuals with primary headaches from the general population...
  26. ncbi request reprint Prevalence and costs of headaches for the public health system in a town in the interior of the state of São Paulo
    M E Bigal
    , , , SP, Brazil
    Arq Neuropsiquiatr 59:504-11. 2001
    ..31 (US$ 70,942.76) corresponding to R$ 7.59 (US$ 6,32) per inhabitant/year. The present study shows the need for epidemiological and economic impact studies, which would provide the basis for the rational use of health funds...
  27. ncbi request reprint Migraine headache disability and health-related quality-of-life: a population-based case-control study from England
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA
    Cephalalgia 23:441-50. 2003
    ..Specifically, individuals classified with moderate to severe work-related disability had lower HRQoL scores than those classified with low disability...
  28. ncbi request reprint Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Neurology 63:1099-101. 2004
    ..The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches...
  29. doi request reprint Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 29:1188-96. 2009
    ..0 vs. -1.3 mmHg) and high-density lipoprotein cholesterol (-3.7 vs. -0.8 mg/dl). Increased weight during migraine treatment is not associated with poor headache treatment outcomes, but is associated with deterioration of CVD risk markers...
  30. ncbi request reprint Migraine practice patterns among neurologists
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 62:1926-31. 2004
    ..To assess the attitudes, knowledge, and practice patterns of US neurologists regarding migraine management relative to the US Headache Consortium Guidelines (the Guidelines)...
  31. ncbi request reprint Migraine preventive therapy: current and emerging treatment options
    A M Rapoport
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902 1251, USA
    Neurol Sci 26:s111-20. 2005
    ..In this paper we review new treatment options for migraine prevention. We start with an overview about migraine and then briefly discuss current indications for migraine prevention and new and emerging preventive medications...
  32. ncbi request reprint Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)--a case report
    M Volcy
    The New England Center for Headache, Stamford, CT 06902, USA
    Cephalalgia 25:470-2. 2005
  33. ncbi request reprint Migraine and adiponectin: is there a connection?
    B L Peterlin
    Department of Neurology, Drexel University College of Medicine, Philadelphia, PA 19102, USA
    Cephalalgia 27:435-46. 2007
    ..Future research may focus on how adiponectin levels are potentially altered during migraine attacks, and how that information can be potentially translated into migraine therapy...
  34. ncbi request reprint Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Cephalalgia 24:321-32. 2004
    ....
  35. ncbi request reprint Which triptan for which patient?
    A M Rapoport
    Department of Neurology, Columbia University, New York, NY, USA
    Neurol Sci 27:S123-9. 2006
    ..New studies have looked at early treatment paradigms and result in better efficacy data, but are difficult to compare due to different endpoints...
  36. ncbi request reprint Headache associated with dialysis: the International Headache Society criteria revisited
    A L Antoniazzi
    Department of Neurology, School of Medicine at Ribeirao Preto, Sao Paulo University, Brazil
    Cephalalgia 23:146-9. 2003
    ..Despite the small number of patients in our study being too low to provide a basis for change in the IHS classification, it serves as an observational report demonstrating possible varieties of headache related to haemodialysis...
  37. pmc Migraine and cardiovascular disease: possible mechanisms of interaction
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 72:1864-71. 2009
    ..Ultimately, it will be important to determine whether MA is a modifiable risk factor for CVD and if preventive medications for migraine or antiplatelet therapy might reduce the risk of CVD in patients with MA...
  38. doi request reprint Validity and reliability of the Migraine-Treatment Optimization Questionnaire
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, New York, NY 10461, USA
    Cephalalgia 29:751-9. 2009
    ..66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-15) and primary care (M-TOQ-5) should be further validated...
  39. doi request reprint Guidelines for controlled trials of drugs in tension-type headache: second edition
    L Bendtsen
    Department of Neurology, University of Copenhagen, Glostrup Hospital, Danish Headache Centre, DK 2600 Glostrup, Denmark
    Cephalalgia 30:1-16. 2010
    ..These developments support the need for also revising the guidelines for drug treatments in tension-type headache. These Guidelines are intended to assist in the design of well-controlled clinical trials in tension-type headache...
  40. ncbi request reprint Indirect costs of migraine in a public Brazilian hospital
    M E Bigal
    Department of Neurology, , , Brazil
    Headache 41:503-8. 2001
    ..42) per employee per year. CONCLUSIONS: Based on its impact on life and the resulting costs, migraine should be considered a public health problem and thus measures should be adopted to reduce its impact on the individual and on society...
  41. doi request reprint Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria
    C Sun-Edelstein
    The New York Headache Center, New York, NY 10021, USA
    Cephalalgia 29:445-52. 2009
    ..We aimed to explain the nature of the controversies surrounding the entities of CM and MOH. A clinical case will be used to illustrate some of the problems faced by clinicians in diagnosing patients with chronic daily headache...
  42. ncbi request reprint The patent foramen ovale-migraine question
    S J Tepper
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Neurol Sci 28:S118-23. 2007
    ..One reported secondary endpoint showed a significant 42% reduction of migraine days, suggesting the need for further randomised, sham-controlled PFO closure studies...
  43. pmc Occipital levels of GABA are related to severe headaches in migraine
    M E Bigal
    Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 70:2078-80. 2008
  44. ncbi request reprint Hemicrania continua: clinical and nosographic update
    A M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Neurol Sci 24:S118-21. 2003
    ..HC will be addressed in the 2003 revision of the International Headache Society (IHS). In this paper we review the clinical features, classification and treatment of HC...
  45. ncbi request reprint Migraine: barriers for care
    F D Sheftell
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT, USA
    Neurol Sci 26:s140-2. 2005
    ....
  46. ncbi request reprint Preventive migraine therapy: what is new
    A M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Neurol Sci 25:S177-85. 2004
    ....
  47. pmc Burning mouth syndrome responsive to pramipexol
    J Stuginski-Barbosa
    The Department of Neurology, School of Medicine at Ribeirao Preto, Ribeirao Preto, SP, Brazil
    J Headache Pain 9:43-5. 2008
    ..We discuss potential pathophysiological implications of our findings...
  48. ncbi request reprint Cluster headache as a manifestation of intracranial inflammatory myofibroblastic tumour: a case report with pathophysiological considerations
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine and The New England Center for Headache, Stamford, CT 06902, USA
    Cephalalgia 23:124-8. 2003
    ....
  49. ncbi request reprint Surgical treatment of patients with refractory migraine headaches and intranasal contact points
    F Behin
    Mount Sinai Medical Center, New York, NY, USA
    Cephalalgia 25:439-43. 2005
    ..Prospective studies are necessary to confirm our results...
  50. ncbi request reprint Why headache treatment fails
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY10461, USA
    Neurology 60:1064-70. 2003
    ..Persistence in treating these patients can be very rewarding. The authors provide a checklist intended to facilitate the management of refractory patients...
  51. ncbi request reprint Patterns of health care utilization for migraine in England and in the United States
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 60:441-8. 2003
    ..To assess patterns of medical consultation, diagnosis, and medication use in representative samples of adults with migraine in England and the United States...
  52. ncbi request reprint ID-migraine
    A M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Neurol Sci 25:S258-60. 2004
    ..Herein we briefly discuss reasons for screening migraine in the primary care setting, and focus on the ID-migraine, a validated migraine screening tool...
  53. ncbi request reprint Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, USA
    Cephalalgia 22:432-8. 2002
    ..The Silberstein and Lipton system is easier to apply, and more parsimonious. These findings support revision of the IHS classification system to include chronic migraine...
  54. ncbi request reprint [Efficacy of three drugs in the treatment of migrainous aura: a randomized placebo-controlled study]
    Marcelo E Bigal
    Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brasil
    Arq Neuropsiquiatr 60:406-9. 2002
    ..Our findings make possible some speculations about the pathophysiology of migraine, as well as about the therapeutic approach of patients presenting migrainous aura...
  55. ncbi request reprint [Menstrual headache: semiological study in 100 cases]
    Lineu Miziara
    Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brasil
    Arq Neuropsiquiatr 61:596-600. 2003
    ..Nauseas and/or vomiting were the most frequent associated symptoms. Finally, we found, among the menstrual headaches, 9 cases of tension type headache, 2 cases of cervicogenic headache and 1 case of stabbing headache...
  56. ncbi request reprint [Headache and hemodialysis: evaluation of the possible triggering factors and of the treatment]
    Ana L Antoniazzi
    Departamento de Neurologia, Hospital das Clinicas, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brasil
    Arq Neuropsiquiatr 60:614-8. 2002
    ..The identification of possible triggering factors and further evaluations of the treatment might increase our knowledge and contribute to reduce the burden of the headaches in patients with chronic renal failure...
  57. ncbi request reprint Tension-type headache: classification and diagnosis
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Curr Pain Headache Rep 9:423-9. 2005
    ..A structured approach to the patient and a better comprehension of this variability of presentation should translate into better quality of care and a more specific diagnosis for TTH sufferers...
  58. ncbi request reprint Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 42:862-71. 2002
    ..Dipyrone (Metamizol) has been used in the acute treatment of migraines in Brazil. Some investigators have found it to be a highly effective medication for migraine pain and associated symptoms...
  59. pmc The differential diagnosis of chronic daily headaches: an algorithm-based approach
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Rousso Bldg, Room 330, Bronx, NY 10461, USA
    J Headache Pain 8:263-72. 2007
    ..The clinical approach to diagnosing CDH is the scope of this review...
  60. ncbi request reprint Body mass index and episodic headaches: a population-based study
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Arch Intern Med 167:1964-70. 2007
    ....
  61. pmc Cutaneous allodynia in the migraine population
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Ann Neurol 63:148-58. 2008
    ..To develop and validate a questionnaire for assessing cutaneous allodynia (CA), and to estimate the prevalence and severity of CA in the migraine population...
  62. doi request reprint Headache as a real disease
    Richard B Lipton
    Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 48:707-10. 2008
    ..Drs. Lipton and Bigal examine the path to acceptance and the impediments that had to be overcome...
  63. ncbi request reprint Headache and hemodialysis: a prospective study
    Ana L Antoniazzi
    Department of Neurology, School of Medicine at Ribeirao Preto, Sao Paulo University, Brazil
    Headache 43:99-102. 2003
    ..To determine the prevalence and clinical characteristics of headache in patients undergoing hemodialysis and to compare the prevalence of headache prior to and following the beginning of a hemodialysis program...
  64. doi request reprint Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment
    Marcelo E Bigal
    Merck Research Laboratories, 1 Merck Drive, Whitehouse Station, NJ 08889, USA
    Neurology 71:559-66. 2008
    ..To evaluate the disability profile and patterns of treatment and health care use for chronic migraine (CM) in the general population, in contrast to episodic migraine...
  65. doi request reprint Clinical course in migraine: conceptualizing migraine transformation
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 71:848-55. 2008
    ..Herein we discuss the evidence that migraine may transform and then consider potential mechanisms as well as risk factors. We close with a brief discussion of clinical strategies that arise based on this perspective on migraine...
  66. ncbi request reprint Chronic daily headache: identification of factors associated with induction and transformation
    Marcelo E Bigal
    Department of Neurology and Epidemiology, Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 42:575-81. 2002
    ..The analysis of factors related to the transformation from episodic to chronic migraine (CM) and to the de novo development of new daily persistent headache (NDPH) remain poorly understood...
  67. ncbi request reprint Migraine with aura versus migraine without aura: pain intensity and associated symptom intensities after placebo
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 42:872-7. 2002
    ..To compare the intensity of pain and associated symptoms after placebo administration in patients with migraine with aura and migraine without aura...
  68. ncbi request reprint [Intramuscular diclofenac in the acute treatment of migraine: a double-blind placebo controlled study]
    Marcelo E Bigal
    Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brasil
    Arq Neuropsiquiatr 60:410-5. 2002
    ..We observed a reduction on the recurrence and rescue medication utilization. Despite being an option to treat migraines attacks in the emergency room settings, diclofenac has a slow onset action and no effects on the associated symptoms...
  69. ncbi request reprint The clinical spectrum of migraine
    Alan M Rapoport
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Compr Ther 29:35-42. 2003
    ..A structured approach to the patient and a better comprehension of this variability of presentation, should translate into better quality of care for migraineurs...
  70. ncbi request reprint The triptan formulations: a critical evaluation
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Arq Neuropsiquiatr 61:313-20. 2003
    ....
  71. ncbi request reprint Opioid therapy and headache: a cause and a cure
    Richard B Lipton
    Neurology 62:1662-3. 2004
  72. ncbi request reprint Obesity and migraine: a population study
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 66:545-50. 2006
    ..To assess the influence of body mass index (BMI) on the prevalence, attack frequency, and clinical features of migraine...
  73. ncbi request reprint New onset headache in a woman with recurrent ear infections
    Brian M Grosberg
    Montefiore Headache Unit, Albert Einstein College of Medicine, Bronx, NY, USA
    Headache 45:240-1. 2005
  74. ncbi request reprint Headache: triumphs in translational research
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Lancet Neurol 4:11-2. 2005
  75. ncbi request reprint When migraine progresses: transformed or chronic migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Expert Rev Neurother 6:297-306. 2006
    ..The risk factors for migraine progression and the mechanisms for progression will be discussed. This review concludes with the prospects for treating transformed migraine and avoiding migraine progression...
  76. ncbi request reprint Multiple cranial neuropathies, headache, and facial pain in a septuagenarian
    Brian M Grosberg
    Albert Einstein College of Medicine, The Montefiore Headache Unit, Bronx, NY, USA
    Headache 44:1038-9. 2004
  77. ncbi request reprint Intranasal medications for the treatment of migraine and cluster headache
    Alan M Rapoport
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    CNS Drugs 18:671-85. 2004
    ..Nevertheless, it is our opinion that nasal preparations increase therapeutic options and may result in faster response times and better efficacy than oral formulations and better patient satisfaction than injectable preparations...
  78. ncbi request reprint Side-locked headache as the chief complaint of inflammatory orbital pseudotumor (myositic form): a case report
    Abouch V Krymchantowski
    Headache Center of Rio, Rio de Janeiro, Brazil
    Headache 46:683-6. 2006
    ..After 5 months she developed orbital and eyelid edema, with painful restrictions to eye movement. Orbital MRI and pathological exam demonstrated inflammatory orbital pseudotumor (myositic form)...
  79. ncbi request reprint Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period
    Chelsea A Meskunas
    Princeton University, Molecular Biology, NJ, USA
    Headache 46:766-72. 2006
    ..To evaluate the substances associated with medication overuse headache (MOH) in a headache center, over the course of the past 15 years...
  80. ncbi request reprint Patterns of use of triptans and reasons for switching them in a tertiary care migraine population
    Fred D Sheftell
    Department of Psychiatry, New York Medical College, NY, USA
    Headache 44:661-8. 2004
    ..To assess the reasons for switching triptans within migraine patients presenting to a specialty clinic...
  81. ncbi request reprint Obesity is a risk factor for transformed migraine but not chronic tension-type headache
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 67:252-7. 2006
    ..To assess the influence of the body mass index (BMI) on the prevalence and severity of chronic daily headache (CDH) and its most frequent subtypes, transformed migraine (TM) and chronic tension-type headache (CTTH)...
  82. ncbi request reprint Tools for diagnosing migraine and measuring its severity
    Richard B Lipton
    Department of Neurology, The Albert Einstein College of Medicine, Bronx, NY, USA
    Headache 44:387-98. 2004
    ..Migraine is assessed to determine how well it meets criteria for screening and the steps that are necessary before firm public policy recommendations for screening for migraine are possible...
  83. ncbi request reprint The medical management of migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Am J Ther 11:130-40. 2004
    ..The clinicians have in their armamentariums an ever-expanding variety of medications. With experience, clinicians can match individual patient needs with the specific characteristics of a drug to optimize therapeutic benefit...
  84. ncbi request reprint Chronic daily headache: is analgesic overuse a cause or a consequence?
    Richard B Lipton
    Neurology 61:154-5. 2003
  85. ncbi request reprint Zolmitriptan (Zomig)
    Alan M Rapoport
    College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Expert Rev Neurother 4:33-41. 2004
    ..5-mg dose at early time points. The physician can now choose the optimum route of delivery of zolmitriptan to stop the headache, increase the likelihood of reducing disability and restore the patient to complete functionality...